Clinical Trial Update: Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating methotrexate for immune-related arthritis or arthralgias was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Arthritis, Arthralgia | Phase 2 | Status: TERMINATED